The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALECTOR INC COM 014442107 19,755 980,894 SH   SOLE   980,894 0 0
BEAM THERAPEUTICS INC COM 07373V105 2,492 31,131 SH   SOLE   31,131 0 0
CONSTELLATION PHARMCETICLS I COM 210373106 12,966 554,325 SH   SOLE   554,325 0 0
DENALI THERAPEUTICS INC COM 24823R105 18,486 323,749 SH   SOLE   323,749 0 0
FIRST FINL BANCORP OH COM 320209109 4,166 173,576 SH   SOLE   173,576 0 0
FOGHORN THERAPEUTICS INC COM 344174107 16,623 1,261,261 SH   SOLE   1,261,261 0 0
NGM BIOPHARMACEUTICALS INC COM 62921N105 43,412 1,493,349 SH   SOLE   1,493,349 0 0
ORIC PHARMACEUTICALS INC COM 68622P109 24,420 996,734 SH   SOLE   996,734 0 0
PINDUODUO INC SPONSORED ADS 722304102 1,094 8,174 SH   SOLE   8,174 0 0
PMV PHARMACEUTICALS INC COM 69353Y103 137,461 4,179,416 SH   SOLE   4,179,416 0 0
RAPT THERAPEUTICS INC COM 75382E109 16,335 735,801 SH   SOLE   735,801 0 0
RUBIUS THERAPEUTICS INC COM 78116T103 339 12,791 SH   SOLE   12,791 0 0
VIR BIOTECHNOLOGY INC COM 92764N102 1,326 25,864 SH   SOLE   25,864 0 0